A considerable number of CRISPR related publications appear to be connected to cancer and infectious diseases, while other diseases such as blood, genetic and nervous system disorders are also explored in the context of CRISPR/Cas technology. Within the broader category of cancer, breast cancer, AML, liver, lung and rectal cancer exhibit a remarkable increase in journal publications in the CRISPR dataset indicating exploration of this technology in the treatment of these cancer or to establish critical genetic targets for these cancer types. Among nervous system disorders, the neurodegenerative diseases Alzheimer's and Parkinson's show a marked increase in publications, especially patents, related to CRISPR indicative of greater commercial interest.